Michael Kaseta - 04 Nov 2024 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role: Director
Signature: /s/Ira Duarte Attorney-in-fact for Michael Kaseta
Issuer symbol: HRTX
Transactions as of: 04 Nov 2024
Net transactions value: +$404,544
Form type: 4
Filing time: 06 Nov 2024, 14:08:57 UTC
Previous filing: 15 Oct 2024
Next filing: 03 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRTX	Common Stock	Award		+37,879			37,879	04 Nov 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRTX	Stock Option (Right to Buy)	Award	$404,544	+227,272		$1.78	227,272	04 Nov 2024	Common Stock	227,272	$1.78	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant (11/4/2024).
F2	Each restricted stock unit represents a contingent right to receive one share of common stock.
F3	The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant (11/4/2024).